The National Prescription Drug Abuse Prevention Strategy: 2011-12 Update is a product of consultations with more than 40 experts from various sectors of society. The Strategy has been endorsed by 30 not-for-profit health and safety organizations and professional associations.
"As a Registered Nurse, I fully understand the need for patients to have access to medications, but unfortunately, I know too well the urgency of the need to reduce prescription drug abuse, as I lost my son, Ryan, to prescription drugs. RYAN's Cause is pleased to grant its endorsement of this strategy."
- Francine Haight, Founder of RYAN's Cause (Reaching Youths Abusing Narcotics)
Click here to obtain a copy of the National Strategy, or email your request to info@claad.org.

News Release: CLAAD Names Millennium Laboratories Industry Ambassador
Company To Serve as Nonprofit’s Liaison to Medication Monitoring and Drug Testing Industry
May 15, 2012 - The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) has named San Diego-based Millennium Laboratories Inc. the organization’s exclusive representative of the medication monitoring and drug testing industry. Millennium joins a diverse coalition of health care providers, law enforcement, parents, teachers, community organizations, and businesses working together to prevent prescription drug abuse while optimizing patient care. News release.

Senate Committee Investigates Pharmaceutical Cos., Nonprofits
April 9, 2012 - The U.S. Senate Finance Committee has requested information from three pharmaceutical manufacturers and seven not-for-profit organizations as part of an investigation into whether the nonprofits promoted misleading information about the risks and benefits of opioid pain relievers. Full story.

Companies Heed Call for Market-Based Solutions to Prescription Drug Abuse Epidemic
April 13, 2012 - At the National Rx Drug Abuse Summit this week, executives from multinational and domestic health care companies met to discuss their efforts to develop market-based solutions to the U.S. prescription drug epidemic. The private-sector meeting took place as federal officials called for industry to develop safer medications and government to be more attentive to the nation’s fastest growing drug problem. News release.